Combining cisplatin and carboplatin complementary or contradictory?
- 1 February 1991
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 2 (2) , 89-91
- https://doi.org/10.1093/oxfordjournals.annonc.a057889
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Cisplatin and carboplatin in combination for the treatment of stage IV ovarian carcinomaAnnals of Oncology, 1991
- Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): Tolerance and relation to leukocyte and buccal cell platinum-DNA adductsAnnals of Oncology, 1991
- Phase I study of the combination of monthly carboplatin and weekly cisplatinAnnals of Oncology, 1991
- Cisplatin Combined With Carboplatin: A New Way of Intensification of Platinum Dose in the Treatment of Advanced Ovarian CancerJNCI Journal of the National Cancer Institute, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Cisplatin/carboplatin cross-resistance in ovarian cancerBritish Journal of Cancer, 1989
- High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation studyEuropean Journal of Cancer and Clinical Oncology, 1987
- JM8, SUCCESSOR TO CISPLATIN IN ADVANCED OVARIAN CARCINOMA?The Lancet, 1983
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982